Primary resistance to integrase inhibitors in Shenzhen.
The Journal of antimicrobial chemotherapy(2023)
Abstract
The prevalence of INSTI resistance in Shenzhen in 2020 was relatively high. Continued surveillance for resistance to INSTIs is recommended and treatment regimens should be adopted based on the pattern of resistance to INSTIs. Dolutegravir or bictegravir is first recommended when considering INSTIs as treatment regimens.
MoreTranslated text
Key words
inhibitors,primary resistance,shenzhen
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined